Form D — Aspira Women's Health Inc.
0001104659-26-076151 · filed Jun 22, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $1,485,000
- Reported amount sold
- $1,485,000
- Minimum investment
- $0
- Investors
- 19
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Aspira Women's Health Inc.
- CIK
- 926617
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 12117 BEE CAVES ROAD
AUSTIN, TX 78738 - Phone
- 512-519-0400
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
JOHN FRASER · Executive OfficerAUSTIN, TX Find on LinkedIn ↗
-
JOHN STRAHLEY · Executive OfficerAUSTIN, TX Find on LinkedIn ↗
-
JEFFREY COHEN · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Jane PINE WOOD · DirectorAUSTIN, TX Find on LinkedIn ↗
-
ELLEN BEAUSANG · DirectorAUSTIN, TX Find on LinkedIn ↗
-
CYNTHIA HUNDORFEAN · DirectorAUSTIN, TX Find on LinkedIn ↗
-
WINFRED PARNELL · DirectorAUSTIN, TX Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗